Global CRO footprint Ozgene operates across Australia, the United States, and the Cayman Islands with AAALAC accredited facilities and embedded vivarium services, presenting a compelling case for multi-region collaborations and cross-border studies with pharma and biotech clients seeking scalable, compliant model generation and breeding services.

End to end offerings From custom model design to breeding, genotyping, phenotyping, collection and vivarium operations, Ozgene provides integrated, end-to-end mouse model solutions, enabling researchers to consolidate vendors, reduce cycle times, and accelerate preclinical programs.

GoGermline advantage Proprietary goGermline and OzBIG platforms enable fast, reliable generation of knockout, knock-in, and humanized models with enhanced 3Rs compliance, offering a competitive differentiator for customers aiming to shorten timelines and improve animal welfare metrics.

Strategic collaborations Recent global collaboration announcements around Shank3 cKO models with CureSHANK and Innoser indicate a growing opportunity in neurodevelopmental disorder programs, suggesting potential for expanded partnerships with academic consortia and patient advocacy groups seeking access to validated models.

Growth indicators Revenue range and diversified global operations, plus distribution rights for JAX strains in key regions, signal a healthy growth trajectory and potential upsell opportunities to larger biotech and pharma firms requiring scalable model platforms, digital workflows, and integrated research infrastructure.